ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) saw a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 11,200 shares, a growth of 154.5% from the January 31st total of 4,400 shares. Based on an average daily trading volume, of 10,100 shares, the days-to-cover ratio is currently 1.1 days.

Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Jane Street Group LLC increased its holdings in ProShares Ultra Nasdaq Biotechnology by 8.4% during the 3rd quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock worth $306,000 after acquiring an additional 374 shares during the period. Tower Research Capital LLC TRC boosted its stake in shares of ProShares Ultra Nasdaq Biotechnology by 31.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,326 shares of the exchange traded fund’s stock valued at $270,000 after purchasing an additional 1,266 shares in the last quarter. Finally, Crowley Wealth Management Inc. bought a new position in shares of ProShares Ultra Nasdaq Biotechnology during the fourth quarter valued at about $51,000.

ProShares Ultra Nasdaq Biotechnology Trading Up 0.8 %

Shares of NASDAQ:BIB traded up $0.45 during mid-day trading on Friday, reaching $54.08. The company had a trading volume of 2,998 shares, compared to its average volume of 10,036. ProShares Ultra Nasdaq Biotechnology has a one year low of $47.19 and a one year high of $69.56. The company’s 50-day moving average price is $53.47 and its 200-day moving average price is $59.14.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently announced a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were paid a $0.3964 dividend. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date was Monday, December 23rd.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.